• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Non-Small Cell Lung Cancer (NSCLC) 
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for NSCLC trials.

DOWNLOAD BROCHURE GET IN TOUCH

Effective solutions for advancing NSCLC research

NSCLC occurs most often in women and men over the age of 70 who have a history of smoking. Oncology studies like NSCLC are complex, and often involve multiple cohorts, diverse tumor types, scattered sites, and expensive medications. More importantly, NSCLC patients face debilitating symptoms that can make participation in studies difficult. That’s where Signant SmartSignals evidence generation solutions can help.

NSCLC-1

Why Signant Health

  • Capture High-Quality COA Data, Faster
  • Provide Empathetic Patient Experience
  • Gain Richer Insights
  • Improve the Consent Process
  • Simplify Supply Management
  • Optimize Participation
  • Capture High-Quality COA Data, Faster

    Capture High-Quality COA Data, Faster

    With over 20 years of experience supporting NSCLC trials, we'll help you capture high-quality COA data from anyone, anywhere. Leverage our pre-validated scales library, collaborative study design approach, and scientific support to launch eCOA for your protocol accurately and on time.
     

  • Provide Empathetic Patient Experience

    Provide Empathetic Patient Experience

    Our patient-focused approach means our solutions are flexible and configurable so you can accommodate your patient populations' needs. For example, we can design larger, well-spaced buttons within our ePRO app interface to help compensate for treatment-related finger numbness. 
     
     

  • Gain Richer Insights

    Gain Richer Insights

    With integrated activity monitoring, you can collect objective data on sleep and activity patterns for enhanced insight into the post-treatment recovery associated with each treatment cycle. Pair with our eCOA for a continuous, real-time view of each patients’ health status.
     
     
     

  • Improve the Consent Process

    Improve the Consent Process

    Signant SmartSignals eConsent uses engaging multimedia to convey complex information and allows patients to flag sections for follow up. The solution also handles the multiple consents and protocol amendments common in NSCLC trials, limiting the risk of inspection findings.
     
     

  • Simplify Supply Management

    Simplify Supply Management

    Signant SmartSignals RTSM uses proprietary algorithms to optimize drug supply efficiency for basket, platform, or umbrella study designs associated with NSCLC trials. You'll be able to launch and apply mid-study protocol changes rapidly.
     
     
     

  • Optimize Participation

    Optimize Participation

    Our secure and compliant Telemedicine solution replaces on-site visits with convenient video consultations. The virtual platform allows study teams to check in more frequently without compromising safety or the site-patient relationship.
     

Leverage our NSCLC experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore NSCLC trial resources
SOLUTION BROCHURE

NSCLC Trial Solutions Overview


GET INSIGHTS
INFOGRAPHIC

The Value of Patient-Reported Outcomes Data in Early-Phase Oncology Studies 





QUICK READ
VIDEO

Unleashing the Power of PROs in Oncology Trials

WATCH [55 mins]

eClinical solutions for NSCLC trials

Ready to learn more?

Discover how Signant can support your current or upcoming NSCLC trials. 

DOWNLOAD BROCHURE GET STARTED